Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
烽火通讯股价突破30元可能性分析
Type of publications
NITAG documentation (58)
Reports (3)
SAGE documentation (2)
Scientific publications (9)
Systematic reviews (SYSVAC) (374)
Regions
Africa (32)
Americas (30)
Eastern Mediterranean (3)
Europe (39)
South-East Asia (6)
Western Pacific (12)
Diseases
Cholera (1)
COVID-19 (193)
Dengue (3)
Diphtheria (4)
Haemophilus influenzae type B (5)
Hepatitis A (1)
Hepatitis B (19)
Herpes zoster (8)
HIV / AIDS (1)
Human papillomavirus (HPV) (35)
Influenza (52)
Japanese encephalitis (4)
Lyme disease, Borreliosis (1)
Measles (15)
Meningococcal disease (10)
Mpox (4)
Mumps (3)
Pertussis (8)
Pneumococcal disease (26)
Poliomyelitis (5)
Rotavirus (12)
RSV (Respiratory syncytial virus) (2)
Rubella (3)
Tetanus (8)
Tuberculosis (4)
Typhoid (5)
Varicella (5)
Yellow fever (3)
Show more
446 results found
2022
∙
Gebeyehu, N. A. Asmare Adela, G. Dagnaw Tegegne, K. Birhan Assfaw, B.
Vaccination dropout among children in Sub-Saharan Africa: Systematic review and meta-analysis
2022
∙
Bollaerts, K. Fletcher, M. A. Suaya, J. A. Hanquet, G. Baay, M. Gessner, B. D.
Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VLA2001 vaccine
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
∙
NACI
Updated guidance on COVID-19 vaccine booster doses in Canada
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19 in France
2022
∙
Royal college of physicians of Ireland
RECOMMENDATIONS REGARDING BIVALENT mRNA COVID-19 VACCINES
2022
∙
SAGE
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register